ACR Convergence 2025| Video: Rheum for Everyone, Episode 26—Ableism

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: pediatric

Ixekizumab Promising for Non-Radiographic Axial SpA; Plus FDA Approves Belimumab for Pediatric Lupus

Michele B. Kaufman, PharmD, BCGP  |  May 21, 2019

Results from a Phase 3 study showed ixekizumab significantly improved the signs and symptoms of non-radiographic axial spondyloarthritis in patients…

Filed under:Biologics/DMARDsDrug Updates Tagged with:belimumabFDAixekizumabnon-radiographic axial spondyloarthritissystemic lupus erythematosus (SLE)U.S. Food and Drug Administration (FDA)

Health Canada Approves Adalimumab for Chronic Non-Infectious Anterior Uveitis in Pediatric Patients

Michele B. Kaufman, PharmD, BCGP  |  April 3, 2019

Health Canada has approved adalimumab for treating chronic non-infectious anterior uveitis in patients 2 years and older…

Filed under:Biologics/DMARDsConditionsDrug UpdatesPediatric Conditions Tagged with:adalimumabnon-infectious anterior uveitisPediatricUveitis

Joining Forces to Advance Pediatric Rheumatology Care

Carina Stanton  |  March 21, 2019

Pediatric rheumatologists are in high demand. In fact, a shortage of pediatric rheumatologists requires more than half of all U.S. children with rheumatic diseases seek care with adult rheumatologists, and this shortage is projected to increase. For the past decade, the ACR’s Special Committee on Pediatric Rheumatology has worked to change this by bringing together…

Filed under:Profiles Tagged with:ACR’s Pediatric Rheumatology Special CommitteeACR/CARRA Mentoring Interest Group for Pediatric Rheumatologists (AMIGO)Jay MehtaPediatric Rheumatology Residency Program

Pediatric Uveitis in the Biologic Age: Risk Factors, Treatment & Outcomes

Lara C. Pullen, PhD  |  March 19, 2019

CHICAGO—The session on the topic of pediatric uveitis at the 2018 ACR/ARHP Annual Meeting began with a presentation by Debra A. Goldstein, MD, professor of ophthalmology and director of the Uveitis Service at the Feinberg School of Medicine, Northwestern University, Chicago. To a room packed with rheumatologists, she explained, “Most of what I am going…

Filed under:ConditionsMeeting Reports Tagged with:2018 ACR/ARHP Annual MeetingUveitis

Pediatric Lupus Outcomes: Researchers Follow Kids into Adulthood

Linda Childers  |  November 19, 2018

A study published in the May issue of Arthritis Care & Research may be the first to examine the long-term outcomes of childhood-onset lupus, otherwise known as pediatric systemic lupus erythematosus (SLE), a chronic, multisystem autoimmune disease with a highly variable clinical course. Previous studies examined cross-sectional views of damage accrued. According to the Childhood…

Filed under:ConditionsResearch RheumSystemic Lupus Erythematosus Tagged with:FlaresSLICC/ACR Damage Index

A New Endowment Will Support Pediatric Rheumatology Fellowships

From the College  |  October 18, 2018

The Rheumatology Research Foundation has received a major donation from Audrey M. Nelson, MD, a retired rheumatologist from the Mayo Clinic in Rochester, Minn. The Audrey M. Nelson, MD, Pediatric Rheumatology Fellowship Endowment in Training will support training awards for pediatric rheumatology fellowships. This generous donation addresses the growing demand for pediatric rheumatologists to ensure…

Filed under:From the CollegeResearch Rheum Tagged with:Dr. Audrey M. NelsonRheumatology Research Foundation

An Overview of Pediatric, Noninfectious Uveitis

Joseph McDonald, MD, Virginia Miraldi Utz, MD, & Sheila T. Angeles-Han, MD, MS  |  October 18, 2018

Uveitis is an inflammation of the uvea, which comprises the iris, ciliary body and choroid. Uveitis can lead to ocular damage and complete visual loss. Noninfectious etiologies for uveitis are the most common in the U.S.1 The estimated incidence of uveitis ranges from 25–52 per 100,000 in adults and five per 100,000 in children. The…

Filed under:ConditionsRheumatoid Arthritis Tagged with:Juvenile Arthritis (JIA)Uveitis

Adalimumab Appears Safe for Treating Pediatric Patients with Autoimmune Disease

Reuters Staff  |  August 8, 2018

NEW YORK (Reuters Health)—Adalimumab appears to be safe for treating pediatric patients with polyarticular juvenile idiopathic arthritis (JIA), enthesitis-related arthritis (ERA), psoriasis and Crohn’s disease (CD), according to data from company-sponsored clinical trials. Adalimumab is an anti-tumor necrosis factor monoclonal antibody with demonstrated efficacy in these conditions, but pediatric safety data remains limited. Dr. Gerd…

Filed under:ConditionsDrug Updates Tagged with:adalimumabCrohn's disease (CD)enthesitis-related arthritis (ERA)polyarticular juvenile idiopathic arthritis (JIA)Psoriasis

The Rate of Disability in Pediatric Patients with SLE

Richard Quinn  |  July 16, 2018

Recent research found 41% of pediatric patients with SLE are affected by at least mild disability, with higher pain scores correlating with increased disability. Mary Beth Son, MD, says determining how these children feel and what affects them daily is vital to “identifying targets we can hit as clinicians to improve their quality of life.”

Filed under:ConditionsSystemic Lupus Erythematosus

Pediatric Rheumatologist Dr. Lynn Punaro Loves a Good Mystery

Kelly Tyrrell  |  May 18, 2018

When Marilynn “Lynn” Punaro, MD, MACR, isn’t working with medical students, seeing patients in the clinic, participating in translational research or performing leadership duties, she’s enjoying a good book—especially a good mystery. This shouldn’t be a surprise. It was mystery that led Dr. Punaro to a career in pediatric rheumatology more than 30 years ago,…

Filed under:Profiles Tagged with:Association of Rheumatology Professionals (ARP)Dr. Lynn Punaro

  • « Previous Page
  • 1
  • …
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 112
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences